Yi Huang

peking university cancer hospital

H指数:41

被引数:5,056

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dexmedetomidine Preemptive Analgesia on Intra- and Postoperative Pain in Noncardiac Surgery: A Randomized, Double-Blind, Controlled Study

右美托咪定预防性镇痛对非心脏手术术中及术后疼痛的影响：一项随机、双盲、对照研究

anesthesia & analgesia

IF0

2026-05-280

OAAI

Differential item functioning in neonatal behavioral neurological assessment in high-risk full-term infants in NICU based on a machine learning approach

基于机器学习方法的NICU高危足月儿新生儿行为神经评估中的项目功能差异

Frontiers in Neuroscience

IF3.2

2025-11-180

OAAI

Population-based nasopharyngeal carcinoma survival in southern China

基于人群的南方中国鼻咽癌生存率

British Journal of Cancer

IF6.8

2025-10-290

Loss of CDS1 impairs the tumorigenic characteristics of nasopharyngeal carcinoma by modulating lipid metabolism

CDS1的缺失通过调控脂质代谢损害了鼻咽癌的成瘤特性

Cell Adhesion & Migration

IF3.5

2025-06-250

Carboxylesterase 4A Inhibits the Malignant Biological Behavior of Nasopharyngeal Carcinoma via the PI3K/AKT Pathway

Carboxylesterase 4A 通过 PI3K/AKT 通路抑制鼻咽癌的恶性生物学行为

TECHNOLOGY IN CANCER RESEARCH & TREATMENT

IF2.8

2025-02-060

Restoration of TFPI2 by LSD1 inhibition suppresses tumor progression and potentiates antitumor immunity in breast cancer

CANCER LETTERS

IF10.1

2024-09-011

PRE

Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-01-104

OAAI

Lipid metabolism reprogramming in head and neck cancer

头颈癌的脂质代谢重编程

FRONTIERS IN ONCOLOGY

IF3.3

2023-10-203

OAAI

Body mass index and body shape before treatment and nasopharyngeal carcinoma prognosis: A population-based patient cohort study in southern China

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2023-04-073

Blood metabolic biomarkers and the risk of head and neck cancer: An epidemiological study in the Swedish AMORIS Cohort

CANCER LETTERS

IF10.1

2023-03-013

New insights into the mechanism of ammonia toxicity: Focus on Cactus

ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY

IF6.1

2023-01-011

OAAI

Dual inhibition of BET and HAT/p300 suppresses colorectal cancer via DR5-and p53/PUMA-mediated cell death

FRONTIERS IN ONCOLOGY

IF3.3

2022-10-127

OAAI

Integration Profiling Between Plasma Lipidomics, Epstein-Barr Virus and Clinical Phenomes in Nasopharyngeal Carcinoma Patients

鼻咽癌患者血浆脂质组学，爱泼斯坦-巴尔病毒和临床表型之间的整合谱

FRONTIERS IN MICROBIOLOGY

IF4.5

2022-06-3010

OAAI

CDK4/6 Inhibition Suppresses p73 Phosphorylation and Activates DR5 to Potentiate Chemotherapy and Immune Checkpoint Blockade

CANCER RESEARCH

IF16.6

2022-02-1115

Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside

错配修复缺陷型结直肠癌的免疫治疗疗效: 从工作台到床边

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

IF8.3

2020-12-01142

OAAI

EIF3H Orchestrates Hippo Pathway-Mediated Oncogenesis via Catalytic Control of YAP Stability

CANCER RESEARCH

IF16.6

2020-06-1526

OAAI

Regulation of KLF4 by posttranslational modification circuitry in endocrine resistance

CELLULAR SIGNALLING

IF3.7

2020-06-0111

OAAI

Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier

THERANOSTICS

IF13.3

2020-01-0131

OAAI

EPHA5 mediates trastuzumab resistance in HER2-positive breast cancers through regulating cancer stem cell-like properties

FASEB JOURNAL

IF4.2

2019-01-0827

PREAI

Electrophilic fatty acids impair RAD51 function and potentiate the effects of DNA-damaging agents on growth of triple-negative breast cells

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2019-01-0116

OAAI

Yi Huang

个人简介

教育背景

工作经历

荣誉奖项

研究方向